Evaluating treatment adherence and patient satisfaction in cutaneous lupus
Cross-sectional Multicenter Study Aimed at Characterizing Adherence to Treatment and Satisfaction With Care in Patients With Cutaneous Lupus
This study looks at how well adults with cutaneous lupus stick to their treatment and how satisfied they are with their care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 233 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 4 sites (Montpellier and 3 other locations) |
| Trial ID | NCT06506214 on ClinicalTrials.gov |
What this trial studies
This multicenter, cross-sectional study aims to assess how well patients with cutaneous lupus adhere to their treatment and their satisfaction with care. It explores factors influencing adherence, such as disease perception, fear of side effects, medication costs, and the doctor-patient relationship. Adherence will be quantified using a visual analog scale, targeting a threshold of 80% or higher on the Medical Adherence Self-Report Inventory. The study will involve adult patients diagnosed with cutaneous lupus who are currently receiving treatment and can complete questionnaires.
Who should consider this trial
Good fit: Ideal candidates are adult patients diagnosed with cutaneous lupus who are currently under treatment and can complete questionnaires.
Not a fit: Patients with systemic lupus, cognitive or psychiatric disorders, or those who are pregnant may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment adherence and satisfaction for patients with cutaneous lupus.
How similar studies have performed: While similar studies have explored treatment adherence in other conditions, this specific focus on cutaneous lupus is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with cutaneous lupus (pure cutaneous or subacute) diagnosed by a dermatologist and under local and/or systemic treatment for cutaneous lupus * No opposition to participation * Patient able to complete the questionnaires * Adult patient Exclusion Criteria: * Systemic lupus with multiple visceral involvement * Cognitive or psychiatric disorders preventing the smooth running of the study * Pregnant woman * Patient under guardianship/curatorship or safeguard of justice
Where this trial is running
Montpellier and 3 other locations
- University Hospital Montpellier — Montpellier, France (Recruiting)
- APHP Hôpital Saint-Louis — Paris, France (Recruiting)
- Hôpital Tenon — Paris, France (Recruiting)
- University Hospital Toulouse — Toulouse, France (Recruiting)
Study contacts
- Principal investigator: Carle PAUL, MD — University Hospital, Toulouse
- Study coordinator: Carle PAUL, MD
- Email: paul.c@chu-toulouse.fr
- Phone: 0567778120
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.